Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
X4 Pharmaceuticals, Inc. (XFOR) Receiveable Turnover data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-101.17M |
|
-- |
|
-- |
|
$107.52M |
|
$-107.52M |
|
$6.43M |
|
$-101.09M |
|
$-101.09M |
|
$-101.17M |
|
$-101.17M |
|
$-101.17M |
|
$-101.17M |
|
$-107.52M |
|
$-107.10M |
|
177.81M |
|
177.81M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$122.08M |
|
$0.74M |
|
$25.18M |
|
$147.26M |
|
$22.86M |
|
$54.57M |
|
$73.30M |
|
$96.16M |
|
$51.10M |
|
$33.75M |
|
$51.10M |
|
167.43M |
|
| Cash Flow Statement Financials | |
$-96.51M |
|
$-14.88M |
|
$88.52M |
|
$123.03M |
|
$100.25M |
|
$-22.78M |
|
$8.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.34 |
|
-- |
|
-- |
|
0.52 |
|
1.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-96.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-197.98% |
|
-299.77% |
|
-68.70% |
|
-95.74% |
|
$0.31 |
|
$-0.54 |
|
$-0.54 |
|